Novel α2-adrenoceptor antagonists show selectivity for α2A- and α2B-adrenoceptor subtypes
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 168 (3) , 381-386
- https://doi.org/10.1016/0014-2999(89)90801-7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence convergTrends in Pharmacological Sciences, 1988
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987
- Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brainLife Sciences, 1986
- A reassessment of the binding of [3H]rauwolscine to membranes from the rat cortexNeuropharmacology, 1986
- Heterogeneity of mammalian α2-adrenoceptors delineated by [3H]yohimbine bindingEuropean Journal of Pharmacology, 1986
- [3H]‐rauwolscine binding to α2‐adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between speciesBritish Journal of Pharmacology, 1985
- Heterogeneity of alpha-2 adrenergic receptorsPharmacology Biochemistry and Behavior, 1985
- α-Adrenoceptor-effector coupling: affinity states or heterogeneity of the α2-adrenoceptor?Clinical Science, 1985
- What do antagonists tell us about α-adrenoceptors?Clinical Science, 1985
- [3H]rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptorsEuropean Journal of Pharmacology, 1982